Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Rocket Pharmaceuticals Inc
About RCKT
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company focused on the development of gene therapies for rare and devastating diseases. The Company has two clinical stage and one pre-clinical stage in vivo adeno-associated viral (AAV) programs in the United States, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is the most common form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart resulting in enlarged heart chambers that are unable to pump blood.
Find out what a historical investment in Rocket Pharmaceuticals Inc would be worth today using our RCKT stock calculator.
Market Capitalisation
$354.88M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.93M
High today
$3.40
Low today
$3.22
Open price
$3.37
52-week high
$7.14
52-week low
$2.19
Ready to start your investing journey with Stake?
Open an accountHow do I buy RCKT shares in Australia?
Buying RCKT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rocket Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RCKT
What is the ticker symbol of Rocket Pharmaceuticals Inc?
The ticker symbol for Rocket Pharmaceuticals Inc is RCKT.
How much is one share of RCKT?
One share of RCKT is valued at $3.24 as of 16 May 2026.
What is the market capitalisation of Rocket Pharmaceuticals Inc RCKT?
As of 16 May 2026 Rocket Pharmaceuticals Inc has a market cap of $354.88M.
What is the 52-week high for Rocket Pharmaceuticals Inc stock?
The Rocket Pharmaceuticals Inc 52-week high stock price is $7.14.
What is the 52-week low for Rocket Pharmaceuticals Inc stock?
The Rocket Pharmaceuticals Inc 52-week low stock price is $2.19.
Can I buy RCKT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RCKT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RCKT on Stake
- Buy RCKT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RCKT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RCKT related stocks